reports
Eyeonid Group AB: 1 director
A director at Eyeonid Group AB bought 200,000 shares at 10.000SEK and the significance rating of the trade was 50/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cle...
Jiangsu Jinling Sports Equipment Co Ltd: 1 director
A director at Jiangsu Jinling Sports Equipment Co Ltd bought 200,000 shares at 13.940CNY and the significance rating of the trade was 58/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over...
Freddie Mac Announces First Quarter 2024 Financial Results
Freddie Mac Announces First Quarter 2024 Financial Results MCLEAN, Va., May 01, 2024 (GLOBE NEWSWIRE) -- Freddie Mac (OTCQB: FMCC) today reported its First Quarter 2024 financial results and filed its Quarterly Report on Form 10-Q with the U.S. Securities and Exchange Commission. The company’s Form 10-Q and earnings press release, along with the First Quarter 2024 financial results supplement are available now on the of the company’s website. The company will hold a call at 9 a.m. Eastern Time (ET) today, May 1, 2024, to share its results with the media. The call will be concurrentl...
Tevogen Bio Announces Full Year 2023 Financial Results and Upcoming Op...
Tevogen Bio Announces Full Year 2023 Financial Results and Upcoming Operational Objectives Acquire cell therapy manufacturing facility with clinical and commercial capabilitiesFurther ExacTcell platform for additional clinical trials based on successful completion of POCHighlight full year financial results and clarify key financial items WARREN, N.J., May 01, 2024 (GLOBE NEWSWIRE) -- (“Tevogen” or “Tevogen Bio”) (Nasdaq: ), a clinical-stage specialty immunotherapy biotech pioneer developing off-the-shelf, genetically unmodified T cell therapeutics in oncology, neurology, and virolo...
electroCore to Announce First Quarter March 31, 2024 Financial Results...
electroCore to Announce First Quarter March 31, 2024 Financial Results on Wednesday, May 8, 2024 ROCKAWAY, N.J., May 01, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it will report financial results for the first quarter ended March 31, 2024, after the close of the market on Wednesday, May 8, 2024. Management will host a conference call and webcast at 4:30 PM EDT to discuss the financial results and answer questions. Wednesday, May 8, 4:30 PM EDTDomestic: 877-407-8835International: Conferen...
Dalata Hotel Group PLC: TVR-Total Voting Rights
Dalata Hotel Group PLC (DAL,DHG) Dalata Hotel Group PLC: TVR-Total Voting Rights 01-May-2024 / 12:58 GMT/BST Total Voting Rights ISE: DHG LSE: DAL In conformity with Regulation 20 of the Transparency (Directive 2004/109/EC) Regulations 2007, Dalata Hotel Group plc announces that: As of 1 May 2024, Dalata Hotel Group plc’s share capital consists of 224,430,160 Ordinary Shares of nominal value €0.01 each. Dalata Hotel Group plc does not hold any Ordinary Shares in treasury. Therefore, the total number of voting rights in Dalata Hotel Group plc is 224,430,160. The ...
Radiation-Tolerant PolarFire® SoC FPGAs Offer Low Power, Zero Configur...
Radiation-Tolerant PolarFire® SoC FPGAs Offer Low Power, Zero Configuration Upsets, RISC-V Architecture for Space Applications Along with Microchip’s Mi-V ecosystem, new device family helps system designers to lower power, size and weight and speed time to market CHANDLER, Ariz., May 01, 2024 (GLOBE NEWSWIRE) -- Developers of spacecraft electronics utilize radiation-tolerant (RT) field programmable gate arrays (FPGAs) to ensure high performance, reliability, power-efficiency and the best-in-class security for emerging space domain threats. To take it a step further and help provide fast...
Samir R. Patel, M.D. Appointed Interim CEO for Akari Therapeutics
Samir R. Patel, M.D. Appointed Interim CEO for Akari Therapeutics BOSTON and LONDON, May 01, 2024 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, today announced leadership changes, including the appointment of experienced life sciences entrepreneur Samir R. Patel, M.D. as interim CEO. Rachelle Jacques will step down as Akari’s Chief Executive Officer effective today. Melissa Bradford-Klug will step down as Akari’s Chief Operating Officer effective today. In connection with Ms. J...
Recursion to Participate in Upcoming Investor Conferences
Recursion to Participate in Upcoming Investor Conferences SALT LAKE CITY, May 01, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its participation in the following investor conferences: Bank of America Securities Healthcare Conference – May 14-16, 202452nd Annual JP Morgan Global Technology Conference – May 20-22, 2024 About Recursion is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recur...
Akari Therapeutics and Peak Bio Announce Portfolio Prioritization Plan...
Akari Therapeutics and Peak Bio Announce Portfolio Prioritization Plan for Combined Go-Forward Merger Entity Prioritization of Peak’s ADC cancer therapeutic platform technology and Akari’s PAS-nomacopan for Geographic Atrophy, a disabling ophthalmic diseaseAkari Therapeutics announces leadership changes in separate Akari press release BOSTON and PLEASANTON, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX, “Akari”) and Peak Bio Inc. (OTC: PKBO, “Peak”) today announced completion of a joint portfolio prioritization review pursuant to which the combined entity...
Locafy Reports Fiscal Third Quarter 2024 Results
Locafy Reports Fiscal Third Quarter 2024 Results Company Striving Towards Near-Term Profitability Following Go-to-Market Approach Revamp and Cost Reduction Initiatives New Pay-Per-Click SEO Pricing Model Gaining Strong Traction in Multiple Market Sectors Streamlined Operations Results in Record Quarterly Gross Margin of 83.6% PERTH, Australia, May 01, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: LCFY, LCFYW) (“Locafy” or the “Company”), a globally recognized software-as-a-service technology company specializing in “entity-based” search engine optimization (SEO), today reported financial result...
Busy Philipps Shines Spotlight on ADHD in Women and Shares her Qelbree...
Busy Philipps Shines Spotlight on ADHD in Women and Shares her Qelbree Story Busy is getting candid about navigating her ADHD diagnosis and treatment experience with Qelbree®The percentage of women newly diagnosed with ADHD between 23-29 and 30-49 years of age nearly doubled in just two years (2020-2022)1Although symptoms are present in childhood, a significant portion of women with ADHD don’t receive a diagnosis until they are adults2 ROCKVILLE, Md., May 01, 2024 (GLOBE NEWSWIRE) -- Actress, author, podcaster, and mother of two, Busy Philipps is teaming up with Supernus Pharmaceuticals ...
Conduent Reports First Quarter 2024 Financial Results
Conduent Reports First Quarter 2024 Financial Results Key Q1 2024 Highlights Revenue: $921MPre-tax Income: $127MAdj. EBITDA Margin(1): 7.5%New business signings ACV(2): $99MNet ARR Activity Metric(2) (TTM): $17M FLORHAM PARK, N.J., May 01, 2024 (GLOBE NEWSWIRE) -- Conduent (NASDAQ: CNDT), a global technology-led business process solutions and services company, today announced its first quarter 2024 financial results. Cliff Skelton, Conduent President and Chief Executive Officer stated, “Q1 2024 is a continued reflection of progress in our portfolio performance overlaid by t...
Carpenter Technology Reports Third Quarter Fiscal Year 2024 Results
Carpenter Technology Reports Third Quarter Fiscal Year 2024 Results Exceeded Third Quarter Operating Income GuidanceIncreasing Fourth Quarter Operating Income OutlookGenerated Positive Free Cash Flow PHILADELPHIA, May 01, 2024 (GLOBE NEWSWIRE) -- Carpenter Technology Corporation (NYSE: CRS) (the “Company”) today announced financial results for the fiscal third quarter ended March 31, 2024. For the quarter, the Company reported operating income of $75.9 million, and earnings per diluted share of $0.12. Excluding noncash special items discussed below, adjusted operating income was $90....
Vislink to Report First Quarter 2024 Financial Results on Wednesday, M...
Vislink to Report First Quarter 2024 Financial Results on Wednesday, May 15, 2024, at 8:30 a.m. ET Mt. Olive, NJ, May 01, 2024 (GLOBE NEWSWIRE) -- (“Vislink” or the “Company”) (Nasdaq: VISL), a global technology leader in the capture, delivery, and management of high-quality live video and associated data in the media and entertainment, law enforcement, and defense markets, will hold a conference call on Wednesday, May 15, 2024, at 8:30 a.m. Eastern Time to discuss its financial results for the first quarter ended March 31, 2024. Financial results will be issued in a press release prior...
TTM Technologies, Inc. Reports First Quarter 2024 Results
TTM Technologies, Inc. Reports First Quarter 2024 Results SANTA ANA, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- TTM Technologies, Inc. (NASDAQ: TTMI), a leading global manufacturer of technology solutions including mission systems, radio frequency (“RF”) components and RF microwave/microelectronic assemblies, quick-turn and technologically advanced printed circuit boards (“PCB”), today reported results for the first quarter 2024, which ended on April 1, 2024. First Quarter 2024 Highlights Net sales were $570.1 millionGAAP net income of $10.5 million, or $0.10 per diluted shareNon-GA...
Benitec Biopharma to Participate in the Citizens JMP Life Science Conf...
Benitec Biopharma to Participate in the Citizens JMP Life Science Conference HAYWARD, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary “Silence and Replace” DNA-directed RNA interference ("ddRNAi") platform, today announced that members of Benitec management will participate in Citizens JMP Life Science Conference, taking place in New York, NY from May 13-14, 2024. Presentation Details:Date: May 13, 2024Time:...
Bionano to Report First Quarter 2024 Financial Results and Host a Conf...
Bionano to Report First Quarter 2024 Financial Results and Host a Conference Call and Webcast on May 8, 2024 SAN DIEGO, May 01, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Wednesday, May 8, 2024, at 4:30 p.m. Eastern Time to report financial results for the first quarter 2024 and to highlight recent corporate progress. Conference Call & Webcast Details Date:Wednesday, May 8th, 2024Time:4:30 p.m. ETParticipant Dial-In:Toll Free: 1-833-630-1956International: 1-412-317-1837Webcast Link: Participants m...
TransUnion to Present at the 2024 Barclays Americas Select Franchise C...
TransUnion to Present at the 2024 Barclays Americas Select Franchise Conference CHICAGO, May 01, 2024 (GLOBE NEWSWIRE) -- TransUnion (NYSE: TRU) today announced that Todd Cello, Executive Vice President, Chief Financial Officer, will present at the Barclays Americas Select Franchise Conference on Tuesday, May 7, 2024. The presentation is scheduled to begin at 8:15 a.m. CDT (2:15 p.m. BST). A live webcast of the presentation will be made available on the TransUnion Investor Relations website at /tru. A replay will also be available on the company’s website following the conclusion of the p...
CTS Announces First Quarter 2024 Results
CTS Announces First Quarter 2024 Results Driving Operational Performance and Profitability; Continued Focus on Diversification LISLE, Ill., May 01, 2024 (GLOBE NEWSWIRE) -- CTS Corporation (NYSE: CTS), a leading global designer and manufacturer of custom engineered solutions that “Sense, Connect and Move,” today announced first quarter 2024 results. “We achieved sales and earnings in line with our expectations. Our teams made progress on operational improvements in the first quarter, which helped offset the unfavorable impact from lower volumes. As anticipated, we are seeing some early...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.